Recruiting Peripheral T-Cell Lymphoma Studies in New York
Randomized Phase IIB Trial of Oral Azacytidine Plus Romidepsin Versus Investigator's Choice in PTCL
The purpose of this study is to find out whether the combination treatment of romidepsin and oral azacytidine is safe and effective in patients with Peripheral T-Cell Lymphoma (PTCL). This study will ...
MB-105 in Patients With CD5 Positive T-cell Lymphoma
This is a single arm, two-stage, Phase 2, open-label, multicenter study of MB-105 in patients with CD5 Positive (CD5+) Relapsed / Refractory T-cell Lymphoma (r/r TCL). This study will apply a Simon tw...
About Peripheral T-Cell Lymphoma Clinical Trials in New York
Peripheral T-cell lymphomas are a diverse group of aggressive non-Hodgkin lymphomas that develop from mature T-cells. They account for about 10-15% of all NHL cases. Treatment includes combination chemotherapy, stem cell transplant, and newer targeted agents.
There are currently 2 peripheral t-cell lymphoma clinical trials recruiting participants in New York, NEW%20YORK. These studies are seeking a combined 96 participants. Research is being sponsored by University of Virginia, March Biosciences Inc. Clinical trial participation is free and participants receive study-related medical care at no cost.
Peripheral T-Cell Lymphoma Clinical Trials in New York — FAQ
Are there peripheral t-cell lymphoma clinical trials in New York?
Yes, there are 2 peripheral t-cell lymphoma clinical trials currently recruiting in New York, NEW%20YORK. Browse the studies on this page to find one that fits.
How do I join a clinical trial in New York?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the New York research site will contact you about next steps.
Are clinical trials in New York free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many New York studies also compensate for your time and travel.
What peripheral t-cell lymphoma treatments are being tested?
The 2 active trials in New York are testing new therapies including novel drugs, biologics, and treatment approaches for peripheral t-cell lymphoma.
Data updated March 2, 2026 from ClinicalTrials.gov